http://www.congoo.com/feed/newschannelsfeed.aspx?chid=69&catid=134News Feed for - Biotechhttp://www.congoo.com/news/addstorycomment.aspx?st=96339081&Channel_ID=69&Category_ID=1342009-11-24T02:23:00-0400 (Reuters Health) * Reports disappointing results of esophagus drug trial * Cephalon shares drop as much as 10 pct * Cephalon delays decision on Ception acquisition By Toni Clarke BOSTON, (Reuters) Reuters Healthhttp://www.congoo.com/news/addstorycomment.aspx?st=96359518&Channel_ID=69&Category_ID=1342009-11-24T01:56:00screens for the effect of altered gene dosage on drug sensitivity in the model organism Saccharomyces cerevisiae provide only a partial picture of the mechanism of action of a drug. RESULTS: Using the Bioscience Technology Onlinehttp://www.congoo.com/news/addstorycomment.aspx?st=96343078&Channel_ID=69&Category_ID=1342009-11-24T01:56:00A report on the impact of genetically modified (GM) crops after the first 13 years of commercial use in the U.S. finds that GM crops have increased pesticide use 318.4 million pounds compared to...Chemical Weekhttp://www.congoo.com/news/addstorycomment.aspx?st=96353421&Channel_ID=69&Category_ID=1342009-11-24T00:26:00Hat off to these people working hard on the maize genome sequencing project. This is a great achievement. While the communities are celebrating this breakthrough, Science, Nature, and NSF should investigate Naturehttp://www.congoo.com/news/addstorycomment.aspx?st=96307573&Channel_ID=69&Category_ID=1342009-11-24T01:49:00(BUSINESS WIRE)--Popular thinking about how to improve food systems for the better often misses the point, according to the results of a three-year global study of salmon production systems from Dalhousie World Energy Sourcehttp://www.congoo.com/news/addstorycomment.aspx?st=96360842&Channel_ID=69&Category_ID=1342009-11-24T04:10:00Inside Industry GEN News Highlights GEN News Highlights Merck Serono, a division of Merck KGaA, will strengthen its global research and development capabilities by establishing a global R&D center Genetic Engineering Newshttp://www.congoo.com/news/addstorycomment.aspx?st=96361941&Channel_ID=69&Category_ID=1342009-11-24T02:28:00Typically conducted in richer, developed countries but now increasingly done in the developing world, genome wide association (GWA) studies raise a host of ethical issues that must be addressed, argues Genetic Engineering Newshttp://www.congoo.com/news/addstorycomment.aspx?st=96337852&Channel_ID=69&Category_ID=1342009-11-24T01:53:00(BUSINESS WIRE)--Biotechnology Industry Organization (BIO): WHAT: For reporters attending the UN Climate Change Conference in Copenhagen, the Biotechnology Industry Organization (BIO) and BioEuropa will World Energy Sourcehttp://www.congoo.com/news/addstorycomment.aspx?st=96365847&Channel_ID=69&Category_ID=1342009-11-24T03:31:00IdentiPHI, Inc.'s SAFsolution 5 Enterprise Edition has been chosen by one of the largest pharmacy benefit managers (PBMs) in the country to enhance biometric authentication and security access across U.S.Pharmacisthttp://www.congoo.com/news/addstorycomment.aspx?st=96365793&Channel_ID=69&Category_ID=1342009-11-24T03:30:00One of Nationâ??s Largest Pharmacy Benefits Managers Selects IdentiPHI Enterprise Biometric Software for Network Security Upgrade Staff IdentiPHI, Inc., an innovative leader in enterprise security solutions U.S.Pharmacisthttp://www.congoo.com/news/addstorycomment.aspx?st=96365364&Channel_ID=69&Category_ID=1342009-11-24T03:24:00There is a 'huge gap in political leadership' on genetically modified organisms in Europe, former European Health Commissioner David Byrne said late last month in a forceful attack both on leadership Agra Nethttp://www.congoo.com/news/addstorycomment.aspx?st=96337904&Channel_ID=69&Category_ID=1342009-11-24T03:18:00Companies mentioned in this article: Amgen THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Freshnews.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96301908&Channel_ID=69&Category_ID=1342009-11-24T01:41:00- Primary study objectives include evaluation of safety and tolerability, as well as selection of a recommended dose for Phase 2 trials - - Continued progress on IAP inhibitor program - ROCKVILLE, Md. Pharmacy Choicehttp://www.congoo.com/news/addstorycomment.aspx?st=96352370&Channel_ID=69&Category_ID=1342009-11-24T00:13:00A talk with associate director of manufacturing Kawa Chiu about initial, and lasting, Right First Time successes.Pharmaceutical Manufacturing Magazinehttp://www.congoo.com/news/addstorycomment.aspx?st=96194670&Channel_ID=69&Category_ID=1342009-11-24T00:23:00- China's Research and Development Organization Will Become the Fourth Key R&D Hub for Merck Serono Worldwide- Merck Serono Plans to Invest More Than 150 Million EURPR wireGENEVA, November 23 GENEVA, PharmiWebhttp://www.congoo.com/news/addstorycomment.aspx?st=96344944&Channel_ID=69&Category_ID=1342009-11-23T23:25:00MISSISSAUGA, ON YM BioSciences understands that the dose-escalation Phase I/II study by Cytopia is investigating the safety and tolerability of CYT387 administered as a daily oral capsule dose in 30-60 Forbes.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96344226&Channel_ID=69&Category_ID=1342009-11-23T23:10:00SPOKANE, Wash.--(Business Wire)-- Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96344804&Channel_ID=69&Category_ID=1342009-11-23T22:51:00Vedomosti The management of General Motors' St. Petersburg plant has fired two workers for carrying out a 'go-slow' strike - union leader Yevgeny Ivanov and member Olga Shafikova. Ivanov received his St. Petersburg Times Russiahttp://www.congoo.com/news/addstorycomment.aspx?st=96342506&Channel_ID=69&Category_ID=1342009-11-23T20:48:00Company: Cephalon, Inc (CEPH) Cephalon (CEPH) shares are falling today on disappointing results from a drug to treat pediatric eosinophilic esophagitis, an inflammation of the esophagus. The results come Zibbhttp://www.congoo.com/news/addstorycomment.aspx?st=96319861&Channel_ID=69&Category_ID=1342009-11-23T16:10:00Nov 23 (Reuters) - Shares of Origin Agritech Ltd soared 67 percent to a year-high on Monday, after the Chinese supplier of crop seeds said on Saturday that its genetically modified phytase corn received Forbes.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96300108&Channel_ID=69&Category_ID=1342009-11-23T13:16:00Companies: Advanced Battery Technologies Inc (ABAT), Human Genome Sciences, Inc. (HGSI), Intel Corp. (INTC), Intuit Inc. (INTU), Linn Energy LLC (LINE) Economic data fails to come to rescue for stocks Zibbhttp://www.congoo.com/news/addstorycomment.aspx?st=96342326&Channel_ID=69&Category_ID=1342009-11-23T20:46:00Biotech Growth trust is planning to raise up to 50m through a new share offering. OrbiMed Capital's Geoffrey Hsu, investment manager to the 70m trust, says the sector has traded on historically low valuations Investment Weekhttp://www.congoo.com/news/addstorycomment.aspx?st=96338089&Channel_ID=69&Category_ID=1342009-11-23T20:12:00Eric Green discusses his priorities as newly appointed director of the US National Human Genome Research Institute. Erika Check Hayden Eric Green is the new director of the US National Human Genome Research Scientific Americanhttp://www.congoo.com/news/addstorycomment.aspx?st=96304549&Channel_ID=69&Category_ID=1342009-11-23T20:57:00(Globes - McClatchy-Tribune Information Services via COMTEX) -- IDBJF | Quote | Chart | News | PowerRating -- Cancer drug development company Biocancell Therapeutics Ltd. (TASE:BICL) has obtained a $500,000 TradingMarketshttp://www.congoo.com/news/addstorycomment.aspx?st=96318459&Channel_ID=69&Category_ID=1342009-11-23T19:49:00The biotechnology sector is a risky investment arena, but investing in such stocks can also be highly rewarding and exciting. A few biotech stocks - DNDN, TRGT, HGSI, VNDA and PLX - covered by our site RTTNews.com